Cargando…
Blood Plasma Metabolome Profiling at Different Stages of Renal Cell Carcinoma
SIMPLE SUMMARY: Renal cell carcinoma (RCC) is one of the most common cancer types. However, the lack of clinical symptoms and validated biomarkers for early stage RCC prevent timely disease diagnosis. The study was focused on revealing potential low molecular biomarkers for early-stage RCC. The unta...
Autores principales: | Maslov, Dmitry L., Trifonova, Oxana P., Lichtenberg, Steven, Balashova, Elena E., Mamedli, Zaman Z., Alferov, Aleksandr A., Stilidi, Ivan S., Lokhov, Petr G., Kushlinskii, Nikolay E., Archakov, Alexander I. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9818272/ https://www.ncbi.nlm.nih.gov/pubmed/36612136 http://dx.doi.org/10.3390/cancers15010140 |
Ejemplares similares
-
Potential Plasma Metabolite Biomarkers of Diabetic Nephropathy: Untargeted Metabolomics Study
por: Trifonova, Oxana P., et al.
Publicado: (2022) -
Holistic Metabolomic Laboratory-Developed Test (LDT): Development and Use for the Diagnosis of Early-Stage Parkinson’s Disease
por: Lokhov, Petr G., et al.
Publicado: (2020) -
Metabolome Profiling in Aging Studies
por: Balashova, Elena E., et al.
Publicado: (2022) -
Mass Spectrometry-Based Metabolomics Analysis of Obese Patients’ Blood Plasma
por: Lokhov, Petr G., et al.
Publicado: (2020) -
Personal Metabolomics: A Global Challenge
por: Lokhov, Petr G., et al.
Publicado: (2021)